The Latest Breaking News from X

European countries, including EU member states, tend to dominate democracy indexes, even as democracy faces threats worldwide.

Tech entrepreneur Bryan Johnson, who spends $2 million annually on anti-aging treatments, refutes claims that Novo Nordisk AS‘s (NYSE:NVO) Ozempic demonstrates anti-aging properties. Johnson disputed a post on social platform X suggesting the diabetes drug reverses biological aging by 3.1 years.

‘I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The Independent

Former X CEO Linda Yaccarino has taken the helm at eMed Population Health, marking a bold shift from social media to digital healthcare leadership amid rising demand for weight-loss drugs and data-driven treatment.

Wedbush analyst Dan Ives raised his price target on Palantir Technologies Inc. (NYSE:PLTR) to $200, citing “hyper growth demand” and “off the charts” commercial expansion.

Newcastle United are signing Benjamin Sesko ahead of Manchester United with just final details to be ironed out

Schwarzenegger’s office urges Newsom not to retaliate against Donald Trump’s Texas power grab, calling it a ‘race to the bottom’

No trains are expected to run to or from Inverness station until Tuesday afternoon at the earliest, while the first Aberdeen-Heathrow flight was cancelled

Palantir Technologies Inc. (NYSE:PLTR) extended gains 4.57% in after-hours trading on Monday, reaching $168 following a blowout second-quarter earnings report. However, technical analyst Mark Newton warned of stretched valuations as the stock’s Relative Strength Index indicator hit 95.